Zoetis Inc Class A
ZTS: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$399.00 | Rhlh | Clmsthndw |
Zoetis Benefits From Pandemic Petboom; Raising Our Fair Value Estimate
Business Strategy and Outlook
Zoetis is the undisputed leader in the global animal health industry, and we believe it possesses the widest moat of all the competitors. Zoetis has set itself apart based on its impressive innovation that shows up across its product portfolio, including a number of drugs for specific pet ailments such as separation anxiety. The firm has also sought to expand its presence into virtually every type of animal-related health market, such as acquaculture and pet diagnostics.